Breast Neoplasms Clinical Trial
Official title:
The Influence of Breast Cancer Risk and Risk Perception on Lifestyle Behaviors Among Women With a Family History: A Mixed Method Approach
Lifestyle behaviors among women with a family history of breast cancer are likely to be
influenced by a number of factors, including both objective risk factors and subjective risk,
or perceived risk. The aims of this mixed method study are twofold and will be explored
through both quantitative (i.e. secondary survey data) and qualitative data (i.e. personal
in-depth interviews) derived from the Sister Study, a large epidemiologic study being
conducted through the National Institute of Environmental Health Sciences, which is
addressing risk factors for breast cancer in sisters of women who have had breast cancer. The
quantitative aims include an exploration of lifestyle behaviors and behavioral differences
between White and African American women, as well as well as an exploration of the
relationships between lifestyle behaviors (i.e. varying levels of objective risk based on
Gail model risk scores, medical risk-reducing factors (i.e. use of Tamoxifen or Raloxifene
and/or prophylactic surgery), as well as additional factors that may be contributors to
perceived risk. This aim will be addressed using data that have already been collected as
part of the baseline activities for the Sister Study. The primary qualitative aim is to gain
a better understanding about perceived risk and the relationship between perceived risk and
lifestyle behaviors in both White and African American women with a family history of breast
cancer. This aim requires the collection of new data through in-person interviews with
between 28 and 40 women, depending on how many interviews are required to achieve "data
saturation."
The mixed method approach will be based on a "complementarity" model, which emphasizes the
use of two different methods to address different aspects of the research problem. Results
from both methods will become integrated into the discussion of the findings and it is
expected that this approach will enrich the study and allow for elaboration of the
quantitative results. The secondary data analysis will be derived from approximately 10,000
women, initially enrolled in the Sister Study, who are between the ages of 35 and 74 and have
had at least one sister affected by breast cancer. Women for the qualitative interviews will
be recruited from a cohort of Sister Study participants residing within North Carolina and
will include equal numbers of both White and African American women. It is expected that 28
women will be needed for qualitative data saturati...
Lifestyle behaviors among women with a family history of breast cancer are likely to be
influenced by a number of factors, including both objective risk factors and subjective risk,
or perceived risk. The aims of this mixed method study are twofold and will be explored
through both quantitative (i.e. secondary survey data) and qualitative data (i.e. personal
in-depth interviews) derived from the Sister Study, a large epidemiologic study being
conducted through the National Institute of Environmental Health Sciences, which is
addressing risk factors for breast cancer in sisters of women who have had breast cancer. The
quantitative aims include an exploration of lifestyle behaviors and behavioral differences
between White and African American women, as well as an exploration of the relationships
between lifestyle behaviors (i.e. varying levels of objective risk based on Gail model risk
scores, medical risk-reducing factors (i.e. use of Tamoxifen or Raloxifene and/or
prophylactic surgery), as well as additional factors that may be contributors to perceived
risk. This aim will be addressed using data that have already been collected as part of the
baseline activities for the Sister Study. The primary qualitative aim is to gain a better
understanding about perceived risk and the relationship between perceived risk and lifestyle
behaviors in both White and African American women with a family history of breast cancer.
This aim requires the collection of new data through in-person interviews with between 28 and
40 women, depending on how many interviews are required to achieve "data saturation."
The mixed method approach will be based on a "complementarity" model, which emphasizes the
use of two different methods to address different aspects of the research problem. Results
from both methods will become integrated into the discussion of the findings and it is
expected that this approach will enrich the study and allow for elaboration of the
quantitative results. The secondary data analysis will be derived from approximately 10,000
women, initially enrolled in the Sister Study, who are between the ages of 35 and 74 and have
had at least one sister affected by breast cancer. Women for the qualitative interviews will
be recruited from a cohort of Sister Study participants residing within North Carolina and
will include equal numbers of both White and African American women. It is expected that 28
women will be needed for qualitative data saturation (i.e. no new information comes forth) to
occur.
The primary outcome measures for the quantitative component of the study are dietary fat
intake, fruit and vegetable consumption, alcohol use and physical activity, which will all be
measured categorically. Physical activities will first be converted into MET (metabolic
equivalent) values and then MET values will be summed across all activities before
categorizing into quartiles or quintiles. Qualitative data will be analyzed through content
analysis, which will involve the identification of common themes or ideas expressed in
response to questions from a semi-structured interview guide developed specifically to
address the aims of the study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Enrolling by invitation |
NCT05558917 -
Comparison Between PECS BLOCK 2 vs ESP BLOCK in Ocnologic Breast Surgery
|
N/A | |
| Active, not recruiting |
NCT03664778 -
Abbreviated Breast MRI After Cancer Treatment
|
||
| Recruiting |
NCT03144622 -
18F-FSPG PET/CT Imaging in Patients With Cancers
|
||
| Completed |
NCT05452499 -
Pain Neuroscience Education and Therapeutic Exercise as a Treatment for Breast Cancer Survivors Living With Sequelae
|
N/A | |
| Active, not recruiting |
NCT04568902 -
Study of H3B-6545 in Japanese Women With Estrogen Receptor (ER)-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Breast Cancer
|
Phase 1 | |
| Completed |
NCT02860585 -
Evaluation of Survival in Patients With Metastatic Breast Cancer Receiving High-dose Chemotherapy With Autologous Haematopoietic Stem Cell Transplantation
|
N/A | |
| Completed |
NCT04059809 -
Photobiomodulation for Breast Cancer Radiodermatitis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04557449 -
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
|
Phase 1/Phase 2 | |
| Completed |
NCT03698942 -
Delphinus SoftVueâ„¢ ROC Reader Study
|
||
| Completed |
NCT00092950 -
Exercise in Women at Risk for Breast Cancer
|
Phase 2 | |
| Terminated |
NCT04123704 -
Sitravatinib in Metastatic Breast Cancer
|
Phase 2 | |
| Not yet recruiting |
NCT02151071 -
The Breast Surgery EnLight and LightPath Imaging System Study
|
Phase 1/Phase 2 | |
| Recruiting |
NCT02934360 -
TR(ACE) Assay Clinical Specimen Study
|
N/A | |
| Active, not recruiting |
NCT02950064 -
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA Mutations
|
Phase 1 | |
| Completed |
NCT02931552 -
Nuevo Amanecer II: Translating a Stress Management Program for Latinas
|
N/A | |
| Not yet recruiting |
NCT02876848 -
A Novel E-Health Approach in Optimizing Treatment for Seniors (OPTIMUM Study)
|
N/A | |
| Recruiting |
NCT02547545 -
Breast Cancer Chemotherapy Risk Prediction Mathematical Model
|
N/A | |
| Completed |
NCT02518477 -
Preventive Intervention Against Lymphedema After Breast Cancer Surgery
|
N/A | |
| Completed |
NCT02652975 -
Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium
|
N/A | |
| Completed |
NCT02303366 -
Pilot Study of Stereotactic Ablation for Oligometastatic Breast Neoplasia in Combination With the Anti-PD-1 Antibody MK-3475
|
Phase 1 |